Aortitis and periaortitis in ankylosing spondylitis

被引:43
作者
Palazzi, Carlo [1 ,2 ,3 ,4 ]
Salvarani, Carlo [5 ]
D'Angelo, Salvatore [1 ,2 ,3 ,4 ,6 ]
Olivieri, Ignazio [1 ,2 ,3 ,4 ]
机构
[1] San Carlo Hosp Potenza, Rheumatol Dept Lucania, Potenza, Italy
[2] San Carlo Hosp Potenza, Rheumatol Dept Lucania, Matera, Italy
[3] Madonna delle Grazie Hosp Matera, Potenza, Italy
[4] Madonna delle Grazie Hosp Matera, Matera, Italy
[5] Arcispedale S Maria Nuova, Div Rheumatol, Reggio Emilia, Italy
[6] Univ Molise, Dept Hlth Sci, Campobasso, Italy
关键词
Aortic; Conduction abnormalities; Heart; HLA B27; Retroperitoneal fibrosis; IDIOPATHIC RETROPERITONEAL FIBROSIS; CONDUCTION DISTURBANCES; ROOT ABNORMALITIES; ASCENDING AORTA; FOLLOW-UP; REGURGITATION; DISEASE; THERAPY; HLA-B27; HEART;
D O I
10.1016/j.jbspin.2010.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aortic involvement is a potential life-threatening complication of ankylosing spondylitis, usually occurring late in the course of this frequent disease. Inflammatory lesions evolving to fibrosis are primarily localized in the aortic root causing regurgitation, but this process can extend into the left atrium (subaortic bump) involving the mitral valve and the heart conduction system. First, second and third degree atrioventricular blocks are the most common conduction alterations described and they can be temporary. Chronic periaortitis has been described in ankylosing spondylitis patients. This disease is characterized by inflammation evolving to fibrosis and it is localized in the periaortic and peri-iliac retroperitoneum. It causes compressive effects on ureters and venous, arterial and lymphatic vessels. Its treatment employs endoscopic and/or surgical procedures and administration of corticosteroids, even in association with immunosuppressive agents. Both aortitis (with conduction system alterations) and periaortitis should be kept in mind by the physicians because they can significantly influence the prognosis of ankylosing spondylitis patients and they can need a rapid treatment. (C) 2010 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:451 / 455
页数:5
相关论文
共 60 条
  • [1] Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis
    Adler, S.
    Lodermeyer, S.
    Gaa, J.
    Heemann, U.
    [J]. RHEUMATOLOGY, 2008, 47 (10) : 1535 - 1538
  • [2] Retroperitoneal fibrosis and ankylosing spondylitis: Which links?
    Afeltra, A
    Gentilucci, UV
    Rabitti, C
    Amoroso, A
    Caricato, M
    Vadacca, M
    Valeri, S
    Zardi, EM
    Coppola, R
    Picardi, A
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 35 (01) : 43 - 48
  • [3] The spectrum of skin, mucosa and other extra-articular manifestations
    Angulo, J
    Espinoza, LR
    [J]. BAILLIERES CLINICAL RHEUMATOLOGY, 1998, 12 (04): : 649 - 664
  • [4] ANSELL BM, 1958, BRIT HEART J, V20, P507
  • [6] HLA-B27 - AN IMPORTANT GENETIC RISK FACTOR FOR LONE AORTIC REGURGITATION AND SEVERE CONDUCTION SYSTEM ABNORMALITIES
    BERGFELDT, L
    INSULANDER, P
    LINDBLOM, D
    MOLLER, E
    EDHAG, O
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 85 (01) : 12 - 18
  • [7] BERGFELDT L, 1984, BRIT HEART J, V51, P184
  • [8] ANKYLOSING-SPONDYLITIS - AN IMPORTANT CAUSE OF SEVERE DISTURBANCES OF THE CARDIAC CONDUCTION SYSTEM - PREVALENCE AMONG 223 PACEMAKER-TREATED MEN
    BERGFELDT, L
    EDHAG, O
    VEDIN, L
    VALLIN, H
    [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (02) : 187 - 191
  • [9] BERGFELDT L, 1982, ACTA MED SCAND, V212, P212
  • [10] HLA-B27-associated cardiac disease
    Bergfeldt, L
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 127 (08) : 621 - 629